Table II.
Logistic regression analysis of the correlation between effectiveness of chemotherapy and clinical factors.
| Variable | Odds ratio | 95% CI | P-value | |
|---|---|---|---|---|
|
| ||||
| Lower | Upper | |||
| ECOG PS score | 2.225 | 1.073 | 4.616 | 0.032a |
| Age | 1.053 | 1.009 | 1.099 | 0.018a |
| Gender | 0.759 | 0.353 | 1.631 | 0.480 |
| Histological type | 0.977 | 0.422 | 2.263 | 0.957 |
| Stage | 2.366 | 1.038 | 5.395 | 0.041a |
| Surgery | 3.441 | 1.431 | 8.273 | 0.006a |
| Chemotherapy regimen | 1.033 | 0.759 | 1.407 | 0.837 |
| CEA | 1.000 | 0.997 | 1.002 | 0.679 |
| CYFRA 21-1 | 1.010 | 0.983 | 1.038 | 0.465 |
| CA 125 | 0.999 | 0.997 | 1.002 | 0.327 |
a
P<0.05. ECOG, Eastern Cooperative Oncology Group; PS, performance status; CEA, carcinoembryonic antigen; CYFRA 21-1, cytokeratin 19 fragment; CA 125; carbohydrate antigen 125.